Trial Profile
Telaprevir With Peginterferon/Ribavirin For Retreatment Of Null Responders With Advanced Fibrosis Post Orthotopic Liver Transplant.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 13 Dec 2015 New trial record